Hinge Health Inc. (NYSE:HNGE – Get Free Report) CFO James Budge sold 55,561 shares of the stock in a transaction dated Thursday, September 10th. The shares were sold at an average price of $89.45, for a total value of $4,969,931.45. Following the completion of the sale, the chief financial officer owned 349,062 shares of the company’s stock, valued at approximately $31,223,595.90. This trade represents a 13.73% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Hinge Health Stock Performance
Shares of HNGE stock opened at $88.86 on Friday. Hinge Health Inc. has a fifty-two week low of $30.08 and a fifty-two week high of $95.57. The firm has a market capitalization of $7.17 billion, a price-to-earnings ratio of 69.42 and a beta of 1.38. The stock’s 50-day simple moving average is $86.14 and its 200-day simple moving average is $63.96.
Hinge Health (NYSE:HNGE – Get Free Report) last released its earnings results on Tuesday, August 4th. The company reported $0.59 EPS for the quarter, topping analysts’ consensus estimates of $0.28 by $0.31. The company had revenue of $212.82 million during the quarter. Hinge Health had a net margin of 15.15% and a return on equity of 51.60%. The firm’s revenue for the quarter was up 53.0% on a year-over-year basis. During the same quarter last year, the business earned $0.59 earnings per share. As a group, equities analysts forecast that Hinge Health Inc. will post 1.25 earnings per share for the current year.
Institutional Investors Weigh In On Hinge Health
Wall Street Analyst Weigh In
Several equities analysts recently issued reports on HNGE shares. Barclays upped their target price on Hinge Health from $97.00 to $100.00 and gave the company an “overweight” rating in a research report on Wednesday, August 5th. Royal Bank Of Canada upped their target price on Hinge Health from $75.00 to $110.00 and gave the company an “outperform” rating in a research report on Wednesday, August 5th. Robert W. Baird increased their price target on shares of Hinge Health from $55.00 to $65.00 and gave the stock a “neutral” rating in a report on Wednesday, June 17th. KeyCorp raised their price target on shares of Hinge Health from $90.00 to $125.00 and gave the stock an “overweight” rating in a research report on Monday, July 13th. Finally, Citizens Jmp lifted their price objective on shares of Hinge Health from $96.00 to $107.00 and gave the company a “market outperform” rating in a research note on Wednesday, August 5th. One research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating, two have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, Hinge Health presently has an average rating of “Moderate Buy” and an average price target of $101.93.
Check Out Our Latest Stock Analysis on Hinge Health
About Hinge Health
Hinge Health, Inc is a digital health company focused on musculoskeletal care. The company provides virtual programs designed to help people manage and improve conditions affecting the back, joints and other areas of the musculoskeletal system, with the goal of supporting conservative care and reducing the need for more invasive treatment.
Its platform combines personalized exercise therapy, digital tools, clinical guidance and behavioral support. Depending on the program, members may use the Hinge Health mobile application, wearable motion sensors and remote care from physical therapists, health coaches and other clinicians.
Featured Stories
- Five stocks we like better than Hinge Health
- Block Makes a Federal Trust Bank Move That Could Reshape Its Fintech Model
- Kroger’s Textbook Entry for Buy-and-Hold Investors
- AST SpaceMobile Looks to Extend Its 30-Day FCC Satellite Testing Window
- Amgen Drops 10% on a Trial It Didn’t Even Run
Receive News & Ratings for Hinge Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hinge Health and related companies with MarketBeat.com's FREE daily email newsletter.
